☆ 4.5 Article

Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives

BREAST CANCER (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Association between financial toxicity and health-related quality of life of patients with gynecologic cancer

Yusuke Kajimoto et al.

Summary: This study aimed to evaluate the association between financial toxicity and health-related quality of life among patients with gynecologic cancer. It found a strong negative correlation between financial difficulty and health-related quality of life, particularly in terms of financial difficulty in gynecologic cancer patients and body image in cervical cancer patients.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2023)

Add to Collection

Review Oncology

Look how far we have come: BREAST cancer detection education on the international stage

Phuong Dung (Yun) Trieu et al.

Summary: Developments in screening mammography have significantly reduced breast cancer mortality rates by 20%-30% over 30 years. However, screening programs vary in each country due to factors such as incidence rate, legislation, health infrastructure, and training opportunities. Mammography, although widely used, misses 15% to 35% of cancers due to errors by radiologists and readers. Some countries lack access to mammography screening, and less developed countries have seen a rapid increase in breast cancer cases. Variations in diagnostic performance have been observed in different countries, with radiologists from developed countries outperforming those from less established countries. Differences in breast features, experiences, and training contribute to these variations. Tailored education training programs are recommended to improve radiologists' interpretation skills. The findings from the review highlight the effectiveness of interventions such as the BREAST program in improving radiologist performance and diagnostic accuracy. Self-testing and immediate feedback loops are crucial for global benchmarking and better breast cancer control.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Review Medicine, General & Internal

Financial Toxicity Among Patients With Breast Cancer Worldwide: A Systematic Review and Meta-analysis

Anam N. Ehsan et al.

Summary: The study aimed to quantify the financial toxicity rate of patients with breast cancer and identify vulnerable populations. The analysis showed that breast cancer patients worldwide face high out-of-pocket costs and financial burden. Financial toxicity was more severe in low- and middle-income countries, but even in high-income countries, over 30% of patients experienced financial distress. Policies are needed to alleviate the financial burden and improve the financial well-being of breast cancer patients.

JAMA NETWORK OPEN (2023)

Add to Collection

Article Oncology

Navigating financial toxicity in patients with cancer: A multidisciplinary management approach

Grace L. Smith et al.

Summary: Approximately half of cancer patients face personal economic burdens known as financial toxicity (FT), which disproportionately affects socioeconomically vulnerable individuals. The primary strategy to address FT at the patient level is financial navigation, which involves comprehensive assessment, guidance towards support resources, and referrals to meet patients' financial needs. Oncologists and clinical provider teams play a crucial role in supporting optimal FT management by proactively assessing patient concerns, streamlining treatment, and incorporating FT concerns into comprehensive care discussions.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Add to Collection

Article Oncology

Fertility Preservation and Financial Hardship among Adolescent and Young Adult Women with Cancer

Clare Meernik et al.

Summary: This study found that young women with cancer who used fertility preservation techniques after diagnosis may face increased financial hardship. More legislation is needed to ensure insurance coverage and improve access to fertility preservation for these individuals.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Add to Collection

Article Oncology

Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer

Yusuke Kajimoto et al.

Summary: The study aimed to validate the internal consistency and reproducibility of the COST tool in patients with gynecologic cancer, and the results showed that the COST tool has good internal consistency and reliable reproducibility in this patient population.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Add to Collection

Article Oncology

Financial Toxicity Following Surgical Treatment for Breast Cancer: A Cross-sectional Pilot Study

Anaeze C. Offodile et al.

Summary: Financial toxicity in breast cancer patients undergoing surgical treatment is associated with baseline demographic, disease, and treatment characteristics. Increasing annual income, using supplemental insurance, and having a higher credit score were found to be associated with lower financial distress. Conversely, factors such as work reduction, increased out-of-pocket spending, advanced tumor stage, and employment status at diagnosis were associated with increased financial distress.

ANNALS OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A)

Tsuguo Iwatani et al.

Summary: This study investigates how Japanese breast cancer patients consider the financial value for their life and health, using the contingent valuation method. The results will help establish a cost-effectiveness evaluation axis for standard treatments of breast cancer.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Protocol for studying the efficiency of ChemoCalc software in helping patients to understand drug treatment costs for breast cancer: A multicenter, open-label, randomized phase 2 study

Sayaka Kuba et al.

Summary: This study aims to assess the effectiveness of the ChemoCalc software in helping patients understand drug cost estimates and whether it subsequently affects treatment choice. By comparing the scores of key questions between the ChemoCalc group and the Usual Explanation group, researchers will determine the impact of the software on treatment decisions.

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2021)

Add to Collection

Article Oncology

Cost health literacy as a physician skill-set: the relationship between oncologist reported knowledge and engagement with patients on financial toxicity

Katrina A. Fischer et al.

SUPPORTIVE CARE IN CANCER (2020)

Add to Collection

Article Oncology

Cancer statistics for adolescents and young adults, 2020

Kimberly D. Miller et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Add to Collection

Review Oncology

Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty

Ken Resnicow et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Add to Collection

Article Oncology

Patient recommendations for reducing long-lasting economic burden after breast cancer

Lorraine T. Dean et al.

CANCER (2019)

Add to Collection

Article Oncology

Current situation and challenges regarding biosimilars in Japan: an example of trastuzumab biosimilars for breast cancer

Fumikata Hara et al.

FUTURE ONCOLOGY (2019)

Add to Collection

Article Integrative & Complementary Medicine

Complementary medicine use and costs in patients with breast cancer who experienced treatment-related side effects: A cross-sectional survey in Korea

Sola Han et al.

COMPLEMENTARY THERAPIES IN MEDICINE (2019)

Add to Collection

Article Oncology

Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18-64 years in BCBS of Texas

Junghyun Kim et al.

BREAST CANCER RESEARCH AND TREATMENT (2018)

Add to Collection

Article Oncology

The Intersection of Financial Toxicity and Family Building in Young Adult Cancer Survivors

Bridgette Thom et al.

CANCER (2018)

Add to Collection

Article Oncology

Unmet Need for Clinician Engagement Regarding Financial Toxicity After Diagnosis of Breast Cancer

Reshma Jagsi et al.

CANCER (2018)

Add to Collection

Article Oncology

A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study

Kazunori Honda et al.

ECANCERMEDICALSCIENCE (2018)

Add to Collection

Article Oncology

Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)

Jonas A. de Souza et al.

CANCER (2017)

Add to Collection

Review Medicine, General & Internal

Breast cancer

Nadia Harbeck et al.

LANCET (2017)

Add to Collection

Article Oncology

Setting the stage for universal financial distress screening in routine cancer care

Nandita Khera et al.

CANCER (2017)

Add to Collection

Article Public, Environmental & Occupational Health

Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years

Benjamin T. Allaire et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2016)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical Diagnosis and Management of Breast Cancer

Elizabeth S. McDonald et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Add to Collection

Article Oncology

International Variation in Female Breast Cancer Incidence and Mortality Rates

Carol E. DeSantis et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)

Add to Collection

Article Oncology

The Development of a Financial Toxicity Patient-Reported Outcome in Cancer The COST Measure

Jonas A. de Souza et al.

CANCER (2014)

Add to Collection

Review Oncology

Breast cancer in young women

Courtney A. Gabriel et al.

BREAST CANCER RESEARCH (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.